Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.
Published . Updated .
This report is about the broad US market.
Directly affected
- BIIB Biogen
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story.
- QQQ Invesco QQQ
Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Biogen belongs to, so it often moves with news about it.
- AMGN Amgen
Amgen is a peer of Biogen in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences
Gilead Sciences is a peer of Biogen in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna
Moderna is a peer of Biogen in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE
argenx SE is a peer of Biogen in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Biogen in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BIIB | -4.59% | -0.71% | base | after close | after close | after close | after close |
| DIANo price data for this ticker | — | — | — | — | — | — | — |
| QQQ | +0.56% | -2.36% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack. Barron's
Source: Barron's
How far Spdr Dow Jones Industrial Average Etf Trust (DIA) has moved since 28 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| BIIB | three days earlier | -0.71% | final price |
| BIIB | five days earlier | -4.59% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | -2.36% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +0.56% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Biogen (BIIB), worth $1,001 - $15,000 on 18 Aug 2026. That is 71 days before publication. Filed 1 Sep 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 36 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 63 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 77 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 79 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 61 days before publication. Filed 8 Oct 2026. View the filing.
- Scott A Kupor, an executive branch official, sold Revolution Medicines (RVMD), worth $1,001 - $15,000 on 30 Jul 2026. That is 90 days before publication. Filed 30 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies tied to this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
In “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence in the 28 Oct 2026 story “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack..” Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- IWM Ishares Tr
Ishares Tr (IWM) is linked, with no stored direction, medium confidence in the 28 Oct 2026 story “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack..” Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
In “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- VTI Vanguard Index Fds
Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence in the 28 Oct 2026 story “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack..” Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
Spdr Dow Jones Industrial Average Etf Trust (DIA)
The 28 Oct 2026 story “Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.” names Spdr Dow Jones Industrial Average Etf Trust (DIA) because of this story.
For Spdr Dow Jones Industrial Average Etf Trust (DIA), the reason on file says SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
A second company, Invesco Qqq Trust, Series 1 (QQQ), is listed for a different reason: Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
The price range for Spdr Dow Jones Industrial Average Etf Trust (DIA), and the dates in the story
DIA traded between 504.92 and 522.62 across 20 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 284.63 across 20 sessions. The latest close on file is 280.18. QQQ traded between 701.18 and 762.84 across 18 sessions. The latest close on file is 721.22.
What the saved facts support for Spdr Dow Jones Industrial Average Etf Trust (DIA)
47 out of 100
“Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.” scores 47 out of 100. The score uses 2 sources, and 5 linked companies.